Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Francis Berenbaum

Showing results (1-10 of 346) with videos related to

Pageof 35
Sort By:
Current Opinion in Rheumatology|August 18, 2004
Signaling transduction: target in osteoarthritisFrancis Berenbaum
Joint Bone Spine|December 14, 2004
COX-3: fact or fancy?Francis Berenbaum
Osteoarthritis and Cartilage|June 22, 2025
Beyond weight loss: GLP-1 emerges as a disease-modifying signal in osteoarthritisFrancis Berenbaum
Arthritis Research & Therapy|December 22, 2007
The quest for the Holy Grail: a disease-modifying osteoarthritis drugFrancis Berenbaum
Best Practice & Research. Clinical Rheumatology|February 5, 2010
Targeted therapies in osteoarthritis: a systematic review of the trials on www.clinicaltrials.govFrancis Berenbaum
Joint Bone Spine|December 17, 2017
e-Health, social media, and rheumatology: Can they get along?Francis Berenbaum
Annals of the Rheumatic Diseases|September 21, 2023
<i>Annals of the Rheumatic Diseases</i> collection on osteoarthritis (2018-2023): hopes and disappointmentsFrancis Berenbaum
Joint Bone Spine|June 25, 2014
Does broccoli protect from osteoarthritis?Francis Berenbaum
Joint Bone Spine|April 26, 2003
NSAIDs and aspirin: friends or foes?Francis Berenbaum
Joint Bone Spine|September 30, 2018
Targeting nerve growth factor to relieve pain from osteoarthritis: What can we expect?Francis Berenbaum
Pageof 35

Showing results (1-10 of 346) with videos related to

Sort By:
Pageof 35
Current Opinion in Rheumatology|August 18, 2004
Signaling transduction: target in osteoarthritisFrancis Berenbaum
Joint Bone Spine|December 14, 2004
COX-3: fact or fancy?Francis Berenbaum
Osteoarthritis and Cartilage|June 22, 2025
Beyond weight loss: GLP-1 emerges as a disease-modifying signal in osteoarthritisFrancis Berenbaum
Arthritis Research & Therapy|December 22, 2007
The quest for the Holy Grail: a disease-modifying osteoarthritis drugFrancis Berenbaum
Best Practice & Research. Clinical Rheumatology|February 5, 2010
Targeted therapies in osteoarthritis: a systematic review of the trials on www.clinicaltrials.govFrancis Berenbaum
Joint Bone Spine|December 17, 2017
e-Health, social media, and rheumatology: Can they get along?Francis Berenbaum
Annals of the Rheumatic Diseases|September 21, 2023
<i>Annals of the Rheumatic Diseases</i> collection on osteoarthritis (2018-2023): hopes and disappointmentsFrancis Berenbaum
Joint Bone Spine|June 25, 2014
Does broccoli protect from osteoarthritis?Francis Berenbaum
Joint Bone Spine|April 26, 2003
NSAIDs and aspirin: friends or foes?Francis Berenbaum
Joint Bone Spine|September 30, 2018
Targeting nerve growth factor to relieve pain from osteoarthritis: What can we expect?Francis Berenbaum
Pageof 35